What people are saying - Write a review
We haven't found any reviews in the usual places.
Prognostic factors and evaluation of effect in drug therapy of breast cancer
Adjuvant systemic therapy in breast cancer
20 other sections not shown
5-Fluorouracil adjuvant adjuvant therapy administration advanced breast cancer aminoglutethimide analogs anticancer agents antigen antitumor activity aromatase inhibitors biochemical biological breast cancer Buzdar cancer cells Cancer Chemotherapy cancer patients Cancer Res carboplatin carcinoma CBDCA CDDP cell lines cisplatin Clin Oncol clinical trials clones CNDP combination chemotherapy compound concentration cyclophosphamide cytotoxic demonstrated developed disease disease-free dose intensity doxorubicin Dr Buzdar Dr Rustum drug resistance effect efficacy endocrine therapy enzyme erbB estradiol estrogen evaluated factors folate FUra gene growth hormone human monoclonal antibodies increased infusion inhibition Japan leucovorin leukemia lung cancer melanoma metastasis metastatic mice modulation monoclonal antibody Mouridsen myelosuppression Nagoya observed oophorectomy oral pharmacokinetic phase plasma postmenopausal preclinical Proc randomized rats receptor recurrence regimen resistant cells response rate Santen schedule screening sensitive shown survival Table tamoxifen tegafur therapeutic tissues total dose toxicity treatment tumor cells vitro